2-oxiranyl-quinoline | 94829-51-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-oxiranyl-quinoline
• 英文别名: 2-quinoline epoxide；2-(Oxiran-2-yl)quinoline
• CAS: 94829-51-3
• 化学式: C₁₁H₉NO
• 分子量: 171.199
• InChiKey: ALQQOFUUKNSEKG-UHFFFAOYSA-N

物化性质

• 沸点：
  331.8±22.0 °C(Predicted)
• 密度：
  1.260±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  25.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-oxiranyl-quinoline 在 N,N-二异丙基乙胺 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 生成 rac-N-(4-chlorobenzyl)-2-(((2-hydroxy-2-(quiolin-2-yl)ethyl)(methyl)amino)methyl)-7-methyl-4-oxo-4,7-dihydrothieno[2,3-b]-pyridine-5-carboxamide
  参考文献：
  名称：

  2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases

  摘要：

  A novel series of 2-aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides have been identified as potent antivirals against human herpesviruses. These compounds demonstrate broad-spectrum inhibition of the herpesvirus polymerases HCMV, HSV-1, EBV, and VZV with high specificity compared to human DNA polymerases. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.03.102
• 作为产物：
  描述：

  喹啉-2-甲醛 在 sodium hydride 作用下， 以 二甲基亚砜 为溶剂， 反应 0.75h， 以42.6%的产率得到2-oxiranyl-quinoline
  参考文献：
  名称：

  [EN] SUBSTITUTED 3-AMINO-THIENO[2,3-B] PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AS IKK INHIBITORS
  [FR] COMPOSES AMIDE D'ACIDE 3-AMINO-THIENO[2,3-B] PYRIDINE-2-CARBOXYLIQUE SUBSTITUE SERVANT D'INHIBITEURS D'IKK

  摘要：

  披露了公式(I)的化合物：其中变量R1、R2、R3和Z如本文所述，它们作为IκB激酶(IKK)复合物的激酶活性的抑制剂是有用的。因此，这些化合物在治疗IKK介导的疾病，包括自身免疫性疾病、炎症性疾病和癌症方面是有用的。还披露了包含这些化合物的药物组合物以及制备这些化合物的方法。

  公开号：

  WO2005056562A1

文献信息

• New benzoyl piperidine compounds
  申请人：——

  公开号：US20040044033A1

  公开（公告）日：2004-03-04

  Provided herein are racemic or enantiomerically enriched benzoyl piperidine compounds and pharmaceutically useful salts thereof, pharmaceutical compositions comprising an effective amount of racemic or enantiomerically enriched benzoyl piperidine compounds to treat central nervous system diseases and methods of treating central nervous system diseases in a mammal, in particular psychoses and cognition disorders.

  提供本申请中的是外消旋或enantioselectively富集的苯甲酰哌啶化合物及其药用盐,药物组合物包括用于治疗中枢神经系统疾病的racemic或enantioselectively富集的苯甲酰哌啶化合物的有效量,以及治疗哺乳动物中枢神经系统疾病的方法,特别是精神疾病和认知障碍。
• [EN] HETEROARYL-ETHANOLAMINE DERIVATIVES AS ANTIVIRAL AGENTS<br/>[FR] DERIVES D'HETEROARYL-ETHANOLAMINE EN TANT QU'AGENTS ANTIVIRAUX
  申请人：UPJOHN CO

  公开号：WO2004022567A1

  公开（公告）日：2004-03-18

  The present invention provides a compound of formula (I), which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.

  本发明提供了一种化合物(I)的公式，其作为抗病毒剂特别是抗疱疹病毒家族的药剂。
• [EN] NEW BENZOYL PIPERIDINE COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES BENZOYLE PIPERIDINE
  申请人：SK CORP

  公开号：WO2004018423A1

  公开（公告）日：2004-03-04

  The present invention concerns racemic or enantiomerically enriched O-carbamoyl, alkoxy, azole or carbonate benzoyl piperidine compounds and pharmaceutically useful salts thereof. The present invention relates to a pharmaceutical composition comprising an effective amount of racemic or enantiomerically enriched benzoyl piperidine compounds to treat central nervous system diseases such as psychosis and cognition disorder and a method of treating central nervous system diseases in a mammal. Also, the present invention is concerned with a process for preparing the same.

  本发明涉及光学异构体富集或混合的O-氨甲酰基、烷氧基、唑类或碳酸酯苯甲酰哌啶化合物及其药用盐。本发明涉及一种制备有效量的混合或光学异构体富集的苯甲酰哌啶化合物的制药组合物，用于治疗中枢神经系统疾病，如精神病和认知障碍，以及治疗哺乳动物中枢神经系统疾病的方法。此外，本发明还涉及一种制备上述化合物的方法。
• Processes for production of optically active epoxides
  申请人：DAICEL CHEMICAL INDUSTRIES CO., LTD.

  公开号：EP0611826A2

  公开（公告）日：1994-08-24

  A microorganism or a preparation thereof is permitted to act on a mixture of enantiomers of an epoxide such as 3-chlorostyrene oxide and the product optically active epoxide is recovered. The microorganism able to produce an optically active (S)-epoxide from the mixture of enantiomers of the epoxide include, for example, a microorganism strain belonging to the genus Candida, the genus Rhodosporidium, the genus Rhodococcus and the genus Nosardioides. Examples of the microorganism capable of producing an optically active (R)-epoxide from said mixture include a microorganism strain belonging to the genus Trichosporon, the genus Geotrichum, the genus Corynebacterium, the genus Micrococcus and the genus Brevibacterium. The objective optically active epoxide can efficiently be obtained with ease and simplicity from the corresponding mixture of enantiomers of the epoxide.

  允许微生物或其制剂作用于环氧化物（如 3-氯苯乙烯氧化物）的对映体混合物，并回收光学活性环氧化物产品。能够从环氧化物的对映体混合物中产生光学活性（S）-环氧化物的微生物包括，例如，属于白色念珠菌属、Rhodosporidium 属、Rhodococcus 属和 Nosardioides 属的微生物菌株。能够从所述混合物中产生光学活性（R）-环氧化物的微生物菌株的例子包括属于三孢菌属、革囊菌属、高丽杆菌属、微球菌属和布雷维杆菌属的微生物菌株。从相应的环氧化物对映体混合物中可以高效、简便地获得具有光学活性的环氧化物。
• Oxazolidinones as novel human CCR8 antagonists
  作者：Jian Jin、Yonghui Wang、Feng Wang、Jeffery K. Kerns、Victoria M. Vinader、Ashley P. Hancock、Matthew J. Lindon、Graeme I. Stevenson、Dwight M. Morrow、Parvathi Rao、Cuc Nguyen、Victoria J. Barrett、Chris Browning、Guido Hartmann、David P. Andrew、Henry M. Sarau、James J. Foley、Anthony J. Jurewicz、James A. Fornwald、Andy J. Harker、Michael L. Moore、Ralph A. Rivero、Kristen E. Belmonte、Helen E. Connor

  DOI：10.1016/j.bmcl.2006.12.076

  日期：2007.3

  High-throughput screening of the corporate compound collection led to the discovery of a novel series of N-substituted-5-aryl-oxazolidinones as potent human CCR8 antagonists. The synthesis, structure-activity relationships, and optimization of the series that led to the identification of SB-649701 (1a), are described. (c) 2006 Elsevier Ltd. All rights reserved.